MYRIAD GENETICS INC short interest in 2026
In 2026, MYRIAD GENETICS INC's disclosed short interest ran from 11.07% of shares outstanding on 15 Jan 2026 to 9.77% on 15 Sep 2026, a change of -1.30 percentage points. The year's high was 12.55% on 13 Mar 2026 and its low 8.03% on 14 Aug 2026, averaging 9.72% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.84 days on 30 Jan 2026. Full history: MYRIAD GENETICS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 11.07% (15 Jan 2026)
- End of year
- 9.77% (15 Sep 2026)
- Change
- -1.30 pp
- High
- 12.55% (13 Mar 2026)
- Low
- 8.03% (14 Aug 2026)
- Average
- 9.72%
- Highest days to cover
- 11.84 (30 Jan 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 11.07% | 11.28 | results (8-K) |
| 30 Jan 2026 | 11.44% | 11.84 | |
| 13 Feb 2026 | 11.56% | 10.36 | |
| 27 Feb 2026 | 12.47% | 7.17 | results (8-K), 10-K filed |
| 13 Mar 2026 | 12.55% | 5.79 | |
| 31 Mar 2026 | 9.40% | 2.94 | |
| 15 Apr 2026 | 8.84% | 7.92 | |
| 30 Apr 2026 | 8.46% | 8.37 | |
| 15 May 2026 | 8.82% | 3.80 | results (8-K), 10-Q filed |
| 29 May 2026 | 9.06% | 4.24 | |
| 15 Jun 2026 | 9.16% | 5.74 | |
| 30 Jun 2026 | 9.07% | 4.37 | |
| 15 Jul 2026 | 8.48% | 7.32 | |
| 31 Jul 2026 | 8.88% | 3.91 | results (8-K), 10-Q filed |
| 14 Aug 2026 | 8.03% | 2.97 | |
| 31 Aug 2026 | 8.20% | 5.00 | |
| 15 Sep 2026 | 9.77% | 4.27 |
See also: MYRIAD GENETICS INC's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.